David I. Wright

Riverside Way, Watchmoor Park, Surrey
Camberley, ENG GU153YL, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Pustular DRESS Syndrome Secondary to Hydroxychloroquine With EBV Reactivation

Pustular DRESS Syndrome Secondary to Hydroxychloroquine With EBV Reactivation

Journal: Journal of drugs in dermatology : JDD
Published: February 28, 2019

Solitary Palmar Keratoacanthoma: Case Report.

Solitary Palmar Keratoacanthoma: Case Report.

Journal: Cureus
Published: May 18, 2018

Treatment Patterns and Outcomes in Patients with Varicose Veins.

Treatment Patterns and Outcomes in Patients with Varicose Veins.

Journal: American health & drug benefits
Published: May 04, 2017

Improvement in patient-reported outcomes of varicose veins following treatment with polidocanol endovenous microfoam.

Improvement in patient-reported outcomes of varicose veins following treatment with polidocanol endovenous microfoam.

Journal: Phlebology
Published: January 25, 2017

Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ(®) Instrument.

Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ(®) Instrument.

Journal: The patient
Published: March 27, 2016

The role of clinically-relevant parameters on the cohesiveness of sclerosing foams in a biomimetic vein model.

The role of clinically-relevant parameters on the cohesiveness of sclerosing foams in a biomimetic vein model.

Journal: Journal of materials science. Materials in medicine
Published: August 17, 2015

The VVSymQ® instrument: Use of a new patient-reported outcome measure for assessment of varicose vein symptoms.

The VVSymQ® instrument: Use of a new patient-reported outcome measure for assessment of varicose vein symptoms.

Journal: Phlebology
Published: July 18, 2015

Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.

Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.

Journal: Phlebology
Published: June 04, 2015

Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.

Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.

Journal: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
Published: January 07, 2015

Durability of treatment effect with polidocanol endovenous microfoam on varicose vein symptoms and appearance (VANISH-2).

Durability of treatment effect with polidocanol endovenous microfoam on varicose vein symptoms and appearance (VANISH-2).

Journal: Journal of vascular surgery. Venous and lymphatic disorders
Published: November 20, 2014

Assessment of thrombotic adverse events and treatment patterns associated with varicose vein treatment.

Assessment of thrombotic adverse events and treatment patterns associated with varicose vein treatment.

Journal: Journal of vascular surgery. Venous and lymphatic disorders
Published: May 28, 2014

The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.

The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.

Journal: Phlebology
Published: July 19, 2013
Showing 1-12 of 17

Last Updated: 09/26/2026